|
Market Closed -
Other stock markets
|
After hours 08:00:00 pm | |||
| 61.96 USD | -2.12% |
|
62.15 | +0.31% |
| Jul. 17 | Many US employers plan to pare health benefits as weight-loss spending soars | RE |
| Jul. 17 | Elevance cuts forecast as US health insurers battle higher costs | RE |
Summary: CVS Health Corporation
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
- The company's MSCI ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Highlights: CVS Health Corporation
- The company shows low valuation levels, with an enterprise value at 0.34 times its sales.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company is one of the best yield companies with high dividend expectations.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses: CVS Health Corporation
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings Chart: CVS Health Corporation
Source: Surperformance
ESG chart: CVS Health Corporation
Source: MSCI
| Fundamentals (Composite) | Global Valuation (Composite) | Financial estimates revisions (Composite) | Capi.($) | ||
|---|---|---|---|---|---|
| 78.38B | |||||
| - | 86.88B | ||||
| 26.84B | |||||
| 23.66B | |||||
| 20.4B | |||||
| 18.63B | |||||
| 16.26B | |||||
| 15.71B | |||||
| 13.73B | |||||
| 13.08B | |||||
| Average | 31.36B | ||||
| Weighted average by Cap. |
Investor (Composite)
Trader (Composite)
ESG MSCI
BBB
Financials
Revenue growth
EPS growth
Capital Efficiency (Composite)
Net Margin
Financial Health (Composite)
Valuation
P/E
EV/Revenue
EV/EBITDA
PBR
Dividend Yield
Revisions
Revenue revisions (1 year)
Revenue revisions (4 months)
Revenue revisions (1 month)
EPS revisions (1 year)
EPS revisions (4 months)
Consensus
Analysts' buy/sell recommendations
Analysts' recommendations evolution (4 months)
Analysts' target price
Analysts' target price evolution (4 months)
Analysts' target price evolution (1 year)
Business Predictability
Surprise rates
Analysts' coverage
Analysts' recommendations divergence
Analysts' Target price divergence
Financial estimates divergence
ESG
Environment
Social
Governance
Controversy
Ethical controversies
Human rights controversies
Tax subsidies controversies
Sharia compliant
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- CVS Stock
- Ratings CVS Health Corporation
Select your edition
All financial news and data tailored to specific country editions
